Pérez-Elizondo AD

Language: Spanish
References: 7
Page: 119-121
PDF size: 161.44 Kb.

ABSTRACT

Basal cell carcinoma (BCC) is the most common malignant skin tumor, accounting for around 75% of cases. It is observed with greater prevalence in those people with light phototypes in particular with a history of chronic sun damage in areas such as the head and neck. Its location in the female genital tract accounts for 2.6%; About 200 cases have been published in the medical literature since its initial description by Temesvary in 1926. It usually appears on the vulva of women between 50 and 80 years of age; mentioning a history of recurrent vulvovaginitis, arsenicism, various trauma, hormonal factors and / or some state of immunosuppression as potential inducing agents.

REFERENCES

1. Giorgi V, Salvini C, Massi D. Rasponilli MR, Carli P. Vulvar basal cell carcinoma: retrospective study and review of literature. Gynecol Oncol. 2005; 97 (1): 192-194.

2. Piura B, Rabinovich A, Dgani R. Basal cell carcinoma of the vulva. J Surg Oncol. 1999; 70 (3): 172-176.

3. Benedet JL, Miller DM, Ehlen TG, Bertrand MA. Basal cell carcinoma of the vulva: clinical features and treatment results in 28 patients. Obstet Gynecol. 1997; 90 (5): 765-768.

4. Wolf K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. Fitzpatrick dermatología en medicina general. 7.^a ed. Editorial Médica Panamericana; 2009.

5. Gibson GE, Ahmed I. Perianal and genital basal cell carcinoma: A clinicopathologic review of 51 cases. J Am Acad Dermatol. 2001; 45 (1): 68-71.

6. Elcas JC, Berek JS. Vulvar cancer: Clinical manifestations, diagnosis, and pathology. 2012.

7. Bolognia JL, Jorizzo LJ, Rapini RP. Dermatology. 2nd ed. London: Mosby Elsevier; 2008.